B-Cell Regulation in Allergic Rhinitis: Important Facts and Emerging Perspectives

Review Article

B-Cell Regulation in Allergic Rhinitis: Important Facts and Emerging Perspectives

Kaiser Jamil ID ^1*
Shyam Gade ²

1 Genetics Department, Bhagwan Mahavir Medical Research centre, Hyderabad, Telangana, India.

2 ENT and Allergy Department, Mahavir Hospital and Research Centre, Hyderabad, Telangana, India.

*Corresponding Author: Kaiser Jamil, Genetics Department, Bhagwan Mahavir Medical Research centre, Hyderabad, Telangana, India.

Citation: Jamil K., Gade S. (2026). B-Cell Regulation in Allergic Rhinitis: Important Facts and Emerging Perspectives, Clinical Case Reports and Studies, BioRes Scientia Publishers. 13(1):1-4. DOI: 10.59657/2837-2565.brs.26.340

Copyright: © 2026 Kaiser Jamil, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: July 17, 2026 | Accepted: July 31, 2026 | Published: August 01, 2026

Abstract

B cells have emerged as indispensable regulators of allergic rhinitis rather than passive producers of IgE antibodies. Their multifaceted roles in antigen presentation, cytokine production, immune tolerance, memory formation, and interaction with other immune cells make them central determinants of disease pathogenesis. Continued research into B-cell biology is expected to revolutionize the diagnosis, prevention, and treatment of allergic rhinitis, paving the way toward personalized immunotherapy and precision allergy medicine. As our understanding deepens, B-cell-targeted interventions may ultimately transform the management of allergic diseases, offering long-lasting relief to millions of affected individuals worldwide.

Keywords: allergic rhinitis; B cells; regulatory B cells; ige; immune tolerance; memory B cells; BAFF; cytokines; precision medicine; immunotherapy

Introduction

Allergic rhinitis (AR) is one of the most prevalent chronic inflammatory disorders worldwide, affecting nearly 20–30% of the global population. Traditionally, allergic rhinitis has been regarded as a T helper 2 (Th2)-mediated disease, where cytokines such as interleukin (IL)-4, IL-5, and IL-13 orchestrate eosinophilic inflammation and immunoglobulin E (IgE) production. However, growing evidence has shifted this paradigm by highlighting the pivotal role of B lymphocytes, not merely as antibody-producing cells but as sophisticated regulators of immune homeostasis.[1]. Understanding B-cell regulation offers new insights into disease mechanisms and opens promising avenues for targeted immunotherapy [2].

Role of B-Cells in allergies

B cells are central players in adaptive immunity. Upon exposure to aeroallergens such as pollen, dust mites, molds, or animal dander, allergen-specific B cells undergo activation through interactions with antigen-presenting cells and T follicular helper (Tfh) cells. These interactions stimulate class-switch recom-bination, leading predominantly to IgE production. IgE antibodies bind with high affinity to FcεRI receptors on mast cells and basophils, priming these effector cells for immediate hypersensitivity reactions upon subsequent allergen exposure [3,4].

In Figure 1. (below) we present the proposed model illustrating the role of B-cell regulation in allergic rhinitis. Aeroallergens activate nasal epithelial cells, leading to the release of alarmins (TSLP, IL-25, and IL-33), which stimulate dendritic cells and promote T follicular helper (Tfh)-mediated B-cell activation. Activated B cells undergo IgE class switching and differentiate into plasma cells and memory B cells, driving allergic inflammation through mast cell and basophil activation. In contrast, regulatory B cells (Bregs) produce IL-10, TGF-β, and IL-35, promoting regulatory T-cell responses and immune tolerance. Emerging therapeutic approaches target B-cell signaling pathways, IgE production, memory B-cell persistence, and enhancement of regulatory B-cell function.

Figure: AI assisted -Showing "B-Cell Regulation in Allergic Rhinitis: From Allergen Sensitization to Immune Tolerance"

(Used vector graphics for publication-quality resolution).

Recent studies have demonstrated that B-cell activity extends well beyond antibody secretion. B cells function as potent antigen-presenting cells capable of activating naïve CD4⁺ T cells and amplifying Th2 immune responses. Furthermore, activated B cells produce cytokines including IL-4, IL-6, IL-10, and transforming growth factor-beta (TGF-β), thereby influencing immune polarization and maintaining a delicate balance between inflammation and immune tolerance [5].

Functions of B-cells and pathogenesis

One of the most intriguing developments in allergy research is the recognition of regulatory B cells (Bregs). Unlike conventional effector B cells, Bregs exert immunosuppressive functions primarily through the secretion of IL-10, IL-35, and TGF-β. These cytokines suppress excessive Th2 responses, promote the expansion of regulatory T cells (Tregs), inhibit inflammatory cytokine production, and help restore immune tolerance toward harmless environmental allergens. Several clinical studies have reported reduced numbers or impaired function of Bregs in patients with persistent allergic rhinitis, suggesting that defective B-cell regulation contributes significantly to disease chronicity.

Table 1: Core B-Cell Roles in AR Pathophysiology

Function	Mechanism	Key Reference
IgE class switching	Local and systemic B cells undergo IL-4/IL-13-driven class switch recombination to IgE upon allergen exposure; germinal center reactions in nasal-associated lymphoid tissue and draining lymph nodes drive affinity maturation [1].	Wu & Zarrin, [6]
Local mucosal IgE production	AR nasal mucosa harbors resident B cells capable of local class switching and IgE synthesis independent of systemic responses — a distinct pathway from classical splenic/lymph node IgE production [2,3].	Kariyawasam & James; Grimsholm et al.[7]
T-B cell crosstalk	CD23 (low-affinity IgE receptor) expressed on switched memory B cells bridges interaction with T follicular helper cells, amplifying IgE responses in AR patients [4].	Yao et al., [8]
B lineage cell/IgE interplay	B lineage cells and total/specific IgE correlate with AR and CRSwNP severity; omalizumab (anti-IgE) reduces free IgE and downstream B-cell-driven inflammation, supporting the IgE axis as a therapeutic target [5].5	Bai & Tan, [9].

AR pathogenesis reflects an imbalance between pathogenic IgE-producing B cells (driven by CD23⁺ memory B cell-Tfh crosstalk and local mucosal class switching) and IL-10-producing regulatory B cells that normally enforce allergen tolerance.

Equally important is the role of memory B cells. Following allergen sensitization, allergen-specific memory B cells persist for prolonged periods, enabling rapid IgE production during repeated allergen exposure. This long-lived immunological memory explains why allergic rhinitis often persists for years despite seasonal variations in allergen exposure. Targeting memory B-cell survival pathways may therefore represent an effective strategy for achieving sustained disease remission.

Signalling pathways and Immunological regulation

Advances in molecular immunology have also identified multiple signaling pathways regulating B-cell activation. Molecules such as CD40-CD40L, BAFF (B-cell activating factor), APRIL (A Proliferation-Inducing Ligand), B-cell receptor (BCR) signaling, phosphoinositide 3-kinase (PI3K), Bruton tyrosine kinase (BTK), and NF-κB pathways collectively govern B-cell proliferation, differentiation, survival, and antibody production. Dysregulation of these pathways contributes to excessive IgE synthesis and persistent allergic inflammation, making them attractive therapeutic targets [10,11].

New areas of Research and emerging technologies

Another exciting area of investigation is the interaction between B cells and epithelial-derived alarmins including thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. These cytokines initiate and amplify type-2 immune responses by promoting B-cell activation and IgE class switching. Simultaneously, innate lymphoid cells (ILC2s) and dendritic cells create an inflammatory microenvironment that further enhances B-cell-mediated allergic responses. This complex cellular cross-talk illustrates that allergic rhinitis is a highly coordinated immune disorder rather than a simple IgE-mediated disease.

Emerging technologies such as single-cell RNA sequencing, high-dimensional flow cytometry, spatial transcriptomics, and multi-omics approaches are transforming our understanding of B-cell heterogeneity in allergic diseases [12]. These techniques have identified distinct B-cell subsets with specialized immunological functions, offering opportunities for precision medicine and biomarker discovery. Personalized profiling of B-cell phenotypes may soon help predict disease severity, treatment response, and long-term prognosis [13,14].

Current therapeutic strategies also reflect the increasing importance of B-cell biology. Allergen-specific immunotherapy (AIT), considered the only disease-modifying treatment for allergic rhinitis, induces immune tolerance partly by enhancing regulatory B-cell populations and promoting the production of allergen-specific IgG4 antibodies that compete with IgE for allergen binding. Similarly, biologic agents targeting IgE, such as anti-IgE monoclonal antibodies, have demonstrated clinical efficacy in reducing allergic inflammation. Future therapies may selectively modulate B-cell signaling pathways, regulatory B-cell expansion, or memory B-cell persistence to achieve more durable disease control with fewer adverse effects [15,16].

Translational implications

From a translational perspective, understanding B-cell regulation has important implications for developing novel diagnostic biomarkers. Circulating allergen-specific B-cell frequencies, regulatory B-cell signatures, cytokine profiles, and B-cell receptor repertoire analyses may complement conventional measurements of serum IgE and eosinophil counts, providing a more comprehensive assessment of disease activity and therapeutic response.

Declarations

Acknowledgements

Authors are thankful to the Chairman of Mahavir Hospital and Research Centre and Research Director of Bhagwan Mahavir Medical Research Centre for the encouragement;

Ethical approval

There are no human participants in this article and informed consent is not required.

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Declaration of the use of AI tools for preparing this editorial

References

Fan, K., Jin, L., & Yu, S. (2022). Roles of regulatory B cells in the pathogenesis of allergic rhinitis. Allergologia et Immunopathologia, 50(5):7–15.
Publisher | Google Scholor
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M., & van de Veen, W. (2021). Regulatory B cells, A to Z. Allergy, 76(9):2699–2715.
Publisher | Google Scholor
Wade-Vallance, A. K., & Allen, C. D. C. (2021). Intrinsic and extrinsic regulation of IgE B cell responses. Current Opinion in Immunology, 72: 221–229.
Publisher | Google Scholor
Allen, C. D. C. (2022). Features of B cell responses relevant to allergic disease. The Journal of Immunology, 208(2):257–266.
Publisher | Google Scholor
Ma, S., Satitsuksanoa, P., Jansen, K., Cevhertas, L., van de Veen, W., & Akdis, M. (2021). B regulatory cells in allergy. Immunological Reviews, 299:10–30.
Publisher | Google Scholor
Wu, L. C., & Zarrin, A. A. (2014). The production and regulation of IgE by the immune system. Nature Reviews Immunology, 14(4):247–259.
Publisher | Google Scholor
Kariyawasam, H., & James, L. (2021). B cells and upper airway disease: Allergic rhinitis and chronic rhinosinusitis with nasal polyps evaluated. Expert Review of Clinical Immunology, 17:445–459.
Publisher | Google Scholor
Yao, Y., Wang, N., Chen, C.-L., Pan, L., Wang, Z.-C., et al. (2020). CD23 expression on switched memory B cells bridges T–B cell interaction in allergic rhinitis. Allergy, 75:2599–2612.
Publisher | Google Scholor
Bai, J., & Tan, B. (2023). B lineage cells and IgE in allergic rhinitis and CRSwNP and the role of omalizumab treatment. American Journal of Rhinology & Allergy, 37:182–192.
Publisher | Google Scholor
Shen, Y., Zhang, N., Yang, Y., Hong, S., & Bachert, C. (2022). Local immunoglobulin E in nasal polyps: Role and modulation. Frontiers in Immunology, 13:961503.
Publisher | Google Scholor
Kliem, C. V., & Schaub, B. (2024). The role of regulatory B cells in immune regulation and childhood allergic asthma. Molecular and Cellular Pediatrics, 11, Article 1.
Publisher | Google Scholor
Wang, H., Tu, J., Zhang, J., Wang, W., Yuan, Z., Li, C., & Wang, Y. (2025). Integrated multi-omics profiling reveals shared mechanistic pathways in asthma–allergic rhinitis comorbidity: A hybrid machine learning framework leveraging Mendelian randomization for precision diagnostics. The World Allergy Organization Journal, 18:101120.
Publisher | Google Scholor
Jamil, K., Gade, S., Asimuddin, M., Fatima, B., Irfana, Neelima, S., Reddy, E., & Sultana, S. (2024). Unravelling the significance of etiology in allergic rhinitis: Leveraging artificial intelligence (AI) to analyze clinical profiles for suitable interventions in South Indian patients. Advances in Clinical Toxicology, 9(2):1–9.
Publisher | Google Scholor
Jamil, K., Asim Uddin, M., & Gade, S. (2023). Leveraging artificial intelligence for targeted response in allergic rhinitis. British Journal of Healthcare and Medical Research, 10(3):281–283.
Publisher | Google Scholor
Jamil, K., Fatima, B., Irfana, Gade, S., Reddy, E., & Mohiuddin, M. (2025). Clinical characterization and therapeutic evaluation of allergic rhinitis. Journal of Advanced Medicine, 1(1):Article e32.
Publisher | Google Scholor
Jamil, K., & Gade, S. (2023). Do genes play a role in allergic rhinitis? Advances in Clinical Toxicology, 8(2).
Publisher | Google Scholor

Delia Teresa Sponza

"Journal of BioMed Research and Reports has created a diverse portfolio in peer review process and provides a wide range scientific and medical novel papers to the scientists. This journal publishes high-quality, peer-reviewed content across all levels of professional development and corporate research and development."

Fatema Tashrifwala

I would like to thank the editorial team for their timely responses and consideration in the publication of my paper. They have been very helpful and accommodating, Lastly, being an open access journal, the published work is freely available and accessible to readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nikhil Vitthal Dayama

I would like to thank the editorial team for their timely and prompt responses and consideration in the publication of my case report. Being an open access journal, it will be great help for the readers to learn the new things without any cost. I would encourage the authors to publish their research in BioRes Scientia and I am happy to be part of this journal.

Boubacar Ahy Diatta

I warmly thank the editorial team for the excellent work they do for continuing medical education in Dermatology. I was able to discover with joy their professionalist, their support and above all appreciate their social generosity on the access to the magazines which is free. This allows an update of scientific knowledge to the entire scientific community. I gladly recommend authors for publication in this journal.

Professor Rajko Igic

The editor of JBRR helped me during the whole process, mainly to eliminate some typographical and other errors. It hastened this publication to be published quickly. Although it is a short text, I believe that the content is important for all medical and other scientific disciplines because eventual addition of the iC citations to citation of the paper would lead to proper assessment of the author's contribution.

Dr Tewodros kassahun Tarekegn

I am thrilled to have had the opportunity to publish my research article in this prestigious journal. The entire process of peer review and publication support provided by the editorial office was exceptional, and it fortified my belief in the quality of my research study. The rigorous peer review process ensured that only the highest quality research was published, and the feedback from the reviewers was extremely helpful. I appreciate the journal's commitment to open access publication, enabling my research to reach a wider audience. The easy-to-use online platform streamlined the submission, peer review, and publication process, and I would confidently recommend this journal to any author looking for efficient, rigorous, and high-quality peer-reviewed publication.

Francis Okello Ooko

I was impressed by your author-centred approach whereby you maintained constant and timely communication with us from the time we submitted the manuscript to acceptance, each time providing critical suggestions to improve the manuscript. In addition, we are encouraged by the thoroughness of your editorial team in checking the originality and overall, quality of the work. Which I believe is very encouraging to other researchers and authors who wish to publish their work in your journals. The published work and the information imparted is freely available and accessible to a wide spectrum of readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nidhi Sapolia

I would like to thank the editorial team of their timely response and guidance in the publication of my case report. They have been extremely helpful at all stages. Being an open access journal, it is of great help for the readers to learn new experiences in different fields, I would highly recommend this journal to authors for high quality peer-reviewed publications.

Dwight L Mckee MD CNS ABIHM

I am very impressed by the high quality of the papers published by the International Journal of Clinical and Molecular Oncology. The editors of this journal are a pleasure to work with, as they are highly responsive even to numerous last minute changes in the manuscript that I recently published with them, and the changes are made on-line the same day they are received. I highly recommend this journal to anyone working in the oncology field, and also value it as a source of cutting edge information in the field.

Kyaw Swar Thet

I would like to thank the editorial team for the opportunity to publish our case report in this prestigious journal. I am very impressed by their timely and efficient handling of the submission, peer review, and publication processes. As residents of a developing, low-income country, we greatly appreciate the discount on submission charges. I hope that as an open access journal, it will facilitate easy access for readers to update their scientific knowledge. I highly recommend this journal for high-quality, peer-reviewed publications. I express my sincere gratitude to the editorial team for their excellent work.

Michel Farah

I would like to thank the editorial team for their quick response and support. The publication support and editorial office were excellent and very helpful. I am happy to have my research article published in this prestigious journal. Our previous case report published in this journal was very successful and viewed by many physicians worldwide.

Kristina Dimitrijevic

I am very positively surprised by thе International Journal of Biomedical and Clinical Research, as well as by the review process itself, which is carried out in a high-quality, timely and professional manner. I am glad that my articles are part of this journal.

Hamid Kasim

I had the pleasure of working with your esteemed journal. I testify that the peer review process was effective and quick, the support from the editorial office is very professional, respectful and friendly and the quality of the review is objective and accurate. I am grateful for the opportunity to work with International Journal of Biomedical & Clinical Research and looking forward for more future cooperation.

Ochala Ejura J

The interaction with the Journal of Women Health Care and Gynaecology has been seamless. I wish to express my profound appreciation to your expert editorial team for the timely response and support. The feedbacks from the peer review process was of great help. Thank you for the discount and opportunity to publish in your reputable journal. I believe that being an Open access journal, it will enable readers easy access to to update their knowledge. I would recommend BioRes Scientia publishers and look forward to more collaborations.

Fernando M Clara

I would like to thank the Journal of Clinical Cardiology and Cardiology Research for the opportunity to publish our work. We greatly appreciate the professionalism demonstrated throughout the editorial process. The rapid peer review, along with the high-quality graphic design, streamlined the process and significantly improved the final presentation of our manuscript. The Journal’s support for scientific dissemination is a meaningful incentive for ongoing research. We commend your editorial efforts and extend our best wishes for the Journal's continued success.

Dr Stylianos Sergios Chatziioannou

Journal of BioMed Research and Reports process was constructive and timely, ensuring that the scientific rigor of the manuscript was upheld. Communication with the editorial office was smooth and supportive throughout, making the overall publication experience very positive. I appreciate the efforts of the editorial team in maintaining high-quality standards, and I am confident that the journal will continue to grow in impact and recognition.

Dr C Zeroual

I am pleased to have worked with the Journal of Brain Research and Neurology. The editorial team was responsive and supportive throughout the process, and the peer review was handled efficiently. I appreciate the opportunity to contribute to this journal and look forward to future collaborations

Mohammadreza Kashefi Baher

I am pleased to have published my research in Dentistry and Oral Health Care. The peer review process was efficient and respectful, and I appreciated the timely communication and support from the editorial team. The journal maintains a professional standard and provides an accessible platform for sharing scientific work. I am grateful for the opportunity and look forward to contributing again in the future.

Cidalia De Fatima Cabral De Frias

I would like to thank the editorial team of International Journal of Biomedical and Clinical Research for their prompt and timely responses during the review process of my article. I had the opportunity to share with the academic community my understanding of the process of caring for a person at the end of life. I recommend the publication of research in the area of palliative care in this prestigious journal.

Roxana Maria Hoza

The peer review process at Hematology Research and Blood Disorders is fair and constructive. The editorial office provides excellent support and timely communication. The journal maintains high quality and is a trusted platform for hematology research.

Dr Hamid Kasim

I was very pleased to collaborate with your esteemed Journal of BioMed Research and Reports, and I also thank the editorial board and the reviewers who enriched my article with their very helpful comments, resulting in a beautiful and elegant presentation. I hope our collaboration will continue in the future, With my respect and best wishes for your continued success.

Dr Sabita Sinha

I would like to sincerely thank the editorial team for their excellent support and for handling the review process smoothly. The entire publication process was well organized and easy to follow. My special thanks go to Katherine Bailey Ma'am for her continuous guidance and support from article submission to publication. Her assistance made the experience very positive and encouraging. I truly enjoyed the process and would highly recommend this Journal of BioMed Research and Reports to other researchers.

Jerome H Check

Clinical Case Reports and Studies peer review is rigorous and constructive, improving clarity and methodology. The editorial office is professional and responsive, with a user-friendly submission system and helpful language-editing support. Overall, the journal maintains high editorial standards and offers strong visibility for clinical research.

M Chandramohan

Our experience with the journal has been highly professional and rewarding. The peer review process was rigorous, transparent, and constructive, providing valuable insights that significantly strengthened the quality of our manuscript. The editorial office offered exceptional support throughout the submission and publication journey, ensuring timely communication and clear guidance at every stage. Their responsiveness and attention to detail made the entire process smooth and efficient. Overall, the journal maintains a high standard of scientific quality and integrity, making it a credible and respected platform for disseminating research. We truly appreciate the commitment to excellence demonstrated by the entire editorial team.